Correlation Between Takeda Pharmaceutical and Intracellular
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Intracellular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Intracellular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and Intracellular Th, you can compare the effects of market volatilities on Takeda Pharmaceutical and Intracellular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Intracellular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Intracellular.
Diversification Opportunities for Takeda Pharmaceutical and Intracellular
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Takeda and Intracellular is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Intracellular Th in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intracellular Th and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Intracellular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intracellular Th has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Intracellular go up and down completely randomly.
Pair Corralation between Takeda Pharmaceutical and Intracellular
Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to under-perform the Intracellular. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical Co is 2.36 times less risky than Intracellular. The stock trades about -0.12 of its potential returns per unit of risk. The Intracellular Th is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 7,300 in Intracellular Th on August 31, 2024 and sell it today you would earn a total of 1,359 from holding Intracellular Th or generate 18.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Takeda Pharmaceutical Co vs. Intracellular Th
Performance |
| Timeline |
| Takeda Pharmaceutical |
| Intracellular Th |
Takeda Pharmaceutical and Intracellular Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Takeda Pharmaceutical and Intracellular
The main advantage of trading using opposite Takeda Pharmaceutical and Intracellular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Intracellular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intracellular will offset losses from the drop in Intracellular's long position.| Takeda Pharmaceutical vs. Emergent Biosolutions | Takeda Pharmaceutical vs. Bausch Health Companies | Takeda Pharmaceutical vs. Neurocrine Biosciences | Takeda Pharmaceutical vs. Teva Pharma Industries |
| Intracellular vs. Alkermes Plc | Intracellular vs. Ironwood Pharmaceuticals | Intracellular vs. Pacira BioSciences, | Intracellular vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |